BP: bodily pain; GH: general health perceptions; MCS: mental component summary; MH: mental health; PCS: physical component summary; PF: physical functioning; RE: role limitations due to emotional problems; RP: role limitations due to physical health; SF: social functioning; VT: vitality.
Figure 2: Change in SF-36 scores from baseline (week 0) to week 26 of the FLEXX trial for IA-BioHA–treated patients. *P<0.05; **P<0.01; ***P<0.001. significant higher scores in GH, VT, MH, and MCS (P<0.05).